Evaluation of the Xpert Clostridium diffcile assay for the diagnosis of Clostridium diffcile infection

Saeam Shin, Minkyung Kim, Myungsook Kim, Heejung Lim, Heejung Kim, Kyungwon Lee, Yunsop Chong

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Infection with Clostridium diffcile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. diffcile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. diffcile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. diffcile strains and differentiate the C. diffcile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. diffcile A & B assays (VIDAS CDAB assay; bioMérieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specifcity, and positive and negative predictive values were 100%, 94.6%, 83.1%, and 100%, respectively, for the Xpert CD assay and 40.8%, 98.0%, 100%, and 88.9%, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. diffcile infection. In addition, this method has excellent usability because it is simple and fast.

Original languageEnglish
Pages (from-to)355-358
Number of pages4
JournalAnnals of laboratory medicine
Volume32
Issue number5
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Clostridium Infections
Clostridium
Assays
Ribotyping
Multiplex Polymerase Chain Reaction
Korea
Cross Infection
France
Real-Time Polymerase Chain Reaction
Polymerase Chain Reaction
Infection
Screening

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Shin, Saeam ; Kim, Minkyung ; Kim, Myungsook ; Lim, Heejung ; Kim, Heejung ; Lee, Kyungwon ; Chong, Yunsop. / Evaluation of the Xpert Clostridium diffcile assay for the diagnosis of Clostridium diffcile infection. In: Annals of laboratory medicine. 2012 ; Vol. 32, No. 5. pp. 355-358.
@article{740dc3d9330f4f1f99714507f1587ef7,
title = "Evaluation of the Xpert Clostridium diffcile assay for the diagnosis of Clostridium diffcile infection",
abstract = "Infection with Clostridium diffcile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. diffcile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. diffcile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. diffcile strains and differentiate the C. diffcile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. diffcile A & B assays (VIDAS CDAB assay; bioM{\'e}rieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specifcity, and positive and negative predictive values were 100{\%}, 94.6{\%}, 83.1{\%}, and 100{\%}, respectively, for the Xpert CD assay and 40.8{\%}, 98.0{\%}, 100{\%}, and 88.9{\%}, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. diffcile infection. In addition, this method has excellent usability because it is simple and fast.",
author = "Saeam Shin and Minkyung Kim and Myungsook Kim and Heejung Lim and Heejung Kim and Kyungwon Lee and Yunsop Chong",
year = "2012",
month = "9",
day = "1",
doi = "10.3343/alm.2012.32.5.355",
language = "English",
volume = "32",
pages = "355--358",
journal = "Annals of Laboratory Medicine",
issn = "2234-3806",
publisher = "Seoul National University",
number = "5",

}

Evaluation of the Xpert Clostridium diffcile assay for the diagnosis of Clostridium diffcile infection. / Shin, Saeam; Kim, Minkyung; Kim, Myungsook; Lim, Heejung; Kim, Heejung; Lee, Kyungwon; Chong, Yunsop.

In: Annals of laboratory medicine, Vol. 32, No. 5, 01.09.2012, p. 355-358.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the Xpert Clostridium diffcile assay for the diagnosis of Clostridium diffcile infection

AU - Shin, Saeam

AU - Kim, Minkyung

AU - Kim, Myungsook

AU - Lim, Heejung

AU - Kim, Heejung

AU - Lee, Kyungwon

AU - Chong, Yunsop

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Infection with Clostridium diffcile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. diffcile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. diffcile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. diffcile strains and differentiate the C. diffcile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. diffcile A & B assays (VIDAS CDAB assay; bioMérieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specifcity, and positive and negative predictive values were 100%, 94.6%, 83.1%, and 100%, respectively, for the Xpert CD assay and 40.8%, 98.0%, 100%, and 88.9%, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. diffcile infection. In addition, this method has excellent usability because it is simple and fast.

AB - Infection with Clostridium diffcile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. diffcile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. diffcile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. diffcile strains and differentiate the C. diffcile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. diffcile A & B assays (VIDAS CDAB assay; bioMérieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specifcity, and positive and negative predictive values were 100%, 94.6%, 83.1%, and 100%, respectively, for the Xpert CD assay and 40.8%, 98.0%, 100%, and 88.9%, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. diffcile infection. In addition, this method has excellent usability because it is simple and fast.

UR - http://www.scopus.com/inward/record.url?scp=84865976286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865976286&partnerID=8YFLogxK

U2 - 10.3343/alm.2012.32.5.355

DO - 10.3343/alm.2012.32.5.355

M3 - Article

C2 - 22950071

AN - SCOPUS:84865976286

VL - 32

SP - 355

EP - 358

JO - Annals of Laboratory Medicine

JF - Annals of Laboratory Medicine

SN - 2234-3806

IS - 5

ER -